A Study of AK111 in Subjects With Moderate-to-severe Plaque Psoriasis

NCT05504317 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Akeso